Skip to main content
Clinical Trials/CTRI/2015/07/006014
CTRI/2015/07/006014
Not yet recruiting
未知

A clinical study to determine the effect of a dietary fiber in patients withgastroesophageal reflux disease (GERD)

Mr Ajay Nilawar0 sites32 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Gastroesophageal reflux disease (GERD)
Sponsor
Mr Ajay Nilawar
Enrollment
32
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Mr Ajay Nilawar

Eligibility Criteria

Inclusion Criteria

  • Males and females 18 \-65 years of age (both inclusive).
  • Patient clinically diagnosed with typical GERD symptoms as heartburn or regurgitation.
  • Patient who does not have relief with diet and lifestyle management or not responding to medical therapy.
  • Patient must be able to understand and complete questionnaires.
  • Patient must be willing to or likely to comply with all study requirements.
  • Patient must be able and willing to provide written informed consent.
  • Women of childbearing potential should have a negative pregnancy test at the time of screening and agree to use contraception during the study.

Exclusion Criteria

  • Complications of gastroesophageal reflux disease including esophageal stricture, Barrettâ??s esophagus or adenocarcinoma of the esophagus, or extraesophageal manifestations of reflux disease (pulmonary or laryngeal disease due to acid reflux) which in the opinion of the Investigator may preclude trial participation.
  • Diagnosis of any other clinically significant medical condition or serious gastrointestinal disorder which in opinion of investigator may jeopardize subjectâ??s safety and preclude trial participation.
  • Patients with medical history of surgery of esophagus, stomach or duodenum.
  • Suffering from any condition which in opinion of the Investigator may interfere with nutrient absorption, distribution, metabolism and excretion
  • e.g. subacute obstruction.
  • Current use of medication which in opinion of the Investigator may interfere with the digestion and nutrient absorption or affect glucose tolerance and estimation.
  • Abuse of drugs or alcohol.
  • Known case of sensitivity to Gluten or Coeliac disease.
  • Pregnant or lactating women.
  • Currently participating or had participated in any other interventional study in last 1 month prior to screening.

Outcomes

Primary Outcomes

Not specified

Similar Trials